#bispecific — Friday, July 10, 2026 (1 items)
| 0 | 💬 0 |
A novel Vdelta1 engager targeting CD19 enhances human Vdelta1 gammadelta T cell responses against CLL and CD19+ hematological malignancies.
(academic.oup.com)
|
Journal of Immunology 2026-07-10 | #immunotherapy #leukemia #cytotoxicity #bispecific #lymphocyte |